Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Short Interest Update

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 191,500 shares, an increase of 334.2% from the December 15th total of 44,100 shares. Based on an average daily volume of 3,540,000 shares, the short-interest ratio is presently 0.1 days. Currently, 2.5% of the company’s shares are sold short.

Catheter Precision Stock Performance

Shares of NYSEAMERICAN:VTAK traded down $0.09 during mid-day trading on Monday, reaching $0.44. 1,043,871 shares of the company’s stock were exchanged, compared to its average volume of 913,610. Catheter Precision has a twelve month low of $0.31 and a twelve month high of $8.40. The company has a current ratio of 0.66, a quick ratio of 0.65 and a debt-to-equity ratio of 0.12.

Catheter Precision Company Profile

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.